series-b
Stage
1
Investors
About
Scancell is a clinical-stage biotechnology company developing active immunotherapies for cancer treatment, focusing on its ImmunoBody and Moditope platforms to generate tumor-specific immunity.
Explore Scancell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.